Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Nardini, Paola ^a   Nãhui Palomino, Rogers Alberto ^a   Parolin, Carola ^a   Laghi, Luca ^b   Foschi, Claudio ^a   Cevenini, Roberto ^a   Vitali, Beatrice ^a   Marangoni, Antonella ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLORIC ACID; LACTIC ACID;

ANTIBIOSIS; CHLAMYDIA TRACHOMATIS; CONDITIONED MEDIUM; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE; PATHOGENICITY; PHARMACOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; VAGINA;

ANTIBIOSIS; CHLAMYDIA TRACHOMATIS; CULTURE MEDIA, CONDITIONED; FEMALE; HUMANS; HYDROCHLORIC ACID; IN VITRO TECHNIQUES; LACTIC ACID; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPECIES SPECIFICITY; VAGINA;

EID: 84976649911     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29024     Document Type: Article

References (43)

1. Larsen, B., Monif, G. R. Understanding the bacterial flora of the female genital tract. Clin. Infect. Dis. 32, e69-77 (2001).
2. Gupta, K. et al. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J. Infect. Dis. 178, 446-450 (1998).
3. Pybus, V., Onderdonk, A. B. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect. 1, 285-292 (1999).
4. Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., Hillier, S. L. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin. Infect. Dis. 37, 319-325 (2003).
5. Martin, H. L. et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863-1868 (1999).
6. Wiesenfeld, H. C., Hillier, S. L., Krohn, M. A., Landers, D. V., Sweet, R. L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 36, 663-668 (2003).
7. Taha, T. E. et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12, 1699-1706 (1998).
8. Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108 Suppl 1, 4680-4687 (2011).
9. Kaewsrichan, J., Peeyananjarassri, K., Kongprasertkit, J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol. Med. Microbiol. 48, 75-83 (2006).
10. Reid, G. et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 9, 27-38 (2011).
11. Spurbeck, R. R., Arvidson, C. G. Lactobacilli at the front line of defense against vaginally acquired infections. Future Microbiol. 6, 567-82 (2011).
12. Barrons, R., Tassone, D. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin. Ther. 30, 453-468 (2008).
13. MacPhee, R. A, Hummelen, R., Bisanz, J. E., Miller, W. L., Reid, G. Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin. Pharmacother. 11, 2985-2995 (2010).
14. Bolton, M., van der Straten, A., Cohen, C. R. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex. Transm. Dis. 35, 214-225 (2008).
15. Senior, K. Chlamydia: a much underestimated STI. Lancet Infect. Dis. 12, 517-518 (2012).
16. Stamm, W. E. Chlamydia trachomatis infections: progress and problems. J. Infect. Dis. 179 Suppl 2, S380-S383 (1999).
17. Haggerty, C. L. et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis. 201 Suppl 2, S134-S155 (2010).
18. Gencay, M. et al. Chlamydia trachomatis detected in human placenta. J. Clin. Pathol. 50, 852-855 (1997).
19. Gencay, M. et al. Chlamydia trachomatis infection in mothers with preterm delivery and in their newborn infants. APMIS 109, 636-640 (2001).
20. Moulder, J. W. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55, 143-190 (1991).
21. Wyrick P. B. Intracellular survival by Chlamydia. Cell Microbiol. 2, 275-282 (2000).
22. Gong, Z., Luna, Y., Yu, P., Fan, H. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS One 9, e107758 (2014).
23. Mastromarino, P. et al. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Int. J. Med. Microbiol. 304, 654-661 (2014).
24. Rizzo, A. et al. Lactobacillus crispatus mediates anti-inflammatory cytokine interleukin-10 induction in response to Chlamydia trachomatis infection in vitro. Int J Med Microbiol. 305(8), 815-827 (2015).
25. Parolin, C. et al. Isolation of vaginal lactobacilli and characterization of anti-Candida activity. PLoS ONE 10(6), e0131220 (2015).
26. De Filippis, F. et al. The same microbiota and a potentially discriminant metabolome in the saliva of omnivore, ovo-lacto-vegetarian and vegan individuals. PLoS ONE 9(11), e112373 (2014).
27. Miller, W. C. et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291, 2229-2236 (2004).
28. Allsworth, J. E., Peipert, J. F. Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am. J. Obstet. Gynecol. 205, 113.e1-6 (2011).
29. Brotman, R. M. et al. Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J. Infect. Dis. 202, 1907-1915 (2010).
30. Hawes, S. E. et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174, 1058-1063 (1996).
31. Martius, J. et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet. Gynecol. 71, 89-95 (1988).
32. Petrova, M. I., Lievens, E., Malik, S., Imholz, N., Lebeer, S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front. Physiol. 6, 81 (2015).
33. Verstraelen, H. et al. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 9, 116 (2009).
34. Cruciani, F. et al. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis. Antimicrob. Agents Chemother. 59, 2825-2834 (2015).
35. Osset, J., Bartolomé, R. M., Garciá, E., Andreu, A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J. Infect. Dis. 183, 485-491 (2001).
36. Vielfort, K., Sjölinder, H., Roos, S., Jonsson, H., Aro, H. Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae. Microbes Infect. 10, 1325-1334 (2008).
37. Aldunate, M. et al. Vaginal concentrations of lactic acid potently inactivate HIV. J. Antimicrob. Chemother. 68, 2015-2025 (2013).
38. Omsland, A., Sager, J., Nair, V., Sturdevant, D. E., Hackstadt T. Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium. Proc. Natl. Acad. Sci. USA 109, 19781-19785 (2012).
39. Saka, H. A. et al. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms. Mol. Microbiol. 82, 1185-1203 (2011).
40. Vitali, B. et al. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 34, 2367-2376 (2015).
41. Finco, O. et al. Approach to discover T-and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc. Natl. Acad. Sci. USA 108, 9969-9974 (2011).
42. Marangoni, A. et al. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice. Atherosclerosis 241, 471-479 (2015).
43. Laghi, L. et al. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob. Agents Chemother. 58, 3411-3420 (2014).